Company Profile

MAE Consulting Group LLC
Profile last edited on: 12/14/2023      CAGE: 76B02      UEI: HA6KN1AL2486

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2013
First Award
2020
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

119 North Road
Deerfield, NH 03037
   (603) 340-7079
   N/A
   maeconsultinggroup.com
Location: Single
Congr. District: 02
County: Rockingham

Public Profile

MAE Group LLC is a full-service medical technology company working towards enabling life saving products to achieve commercial market penetration. With expertise in developing drug, biologics, medical device and in vitro diagnostic device technology for global markets to maximize ROI, the firm's core services organzied around regulatory affairs, clinical requirements, quality systems, and software and cybersecurity/network security management. With a consultative approach that is designed to define the needs of each individual deliverable for a project offering a well-characterized approach to finding the best path to market, assigned teams efficiently drive milestones and deliverables to achieve results and success to the satisfaction of clients while evaluating and de-risking any areas that may preclude achieving success.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 1 NIH $300,000
Project Title: Tumor Bed Implant for Simultaneous Heat and Radiation of Resectable Brain Tumors

Key People / Management

  Paul Rath Stauffer

Company News

There are no news available.